...
MRUSMID

Merus N.V.

HealthcareBiotechnology
$90.00
$0.00(+0.00%)
52W$33.19
$97.14
Updated Feb 28, 12:00 AM
RSI15
RS Rating86/99
Beta0.90
Volatility70%
F-Score4/9
Mkt Cap$6.8B
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Merus N.V. shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is leading (RS Rating: 86), indicating clear outperformance against the broad market. Earnings growth of 14% provides fundamental context to the price action. However, RSI is deeply oversold at 15, suggesting potential for a mean-reversion bounce.

Relative Strength
86
out of 99
Market Leader
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
0.90
vs S&P 500
MARKET
52W Position
89%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$95.43
50 SMA > 100 SMA$85.94
100 SMA > 150 SMA$76.75
150 SMA > 200 SMA$68.44

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$95.36-5.62%BELOW
50 SMA$95.43-5.69%BELOW
100 SMA$85.94+4.72%ABOVE
150 SMA$76.75+17.26%ABOVE
200 SMA$68.44+31.51%ABOVE

Price Performance

1D+0.0%
1W
1M
3M-6.4%
6M+36.2%
YTD+0.0%
1Y+91.1%
3Y+67.7%
52-Week Trading Range89% from low
$90.00
52W Low$33.19
52W High$97.14

Technical Indicators

RSI (14)OVERSOLD
14.9
305070
VCP ScoreCOOL
5/10
Base depth: 11.1%

Risk Profile

Beta
0.90
52W Vol
70%
ATR
$
Max DD (1Y)
-29%

Volume Analysis

Today
50D Avg
520.2K
Vol Ratio
0.00x
Liquidity
MODERATE

Earnings Momentum

Q4'24+57%
$-0.45
Q1'25-137%
$-1.40
Q2'25-175%
$-2.23
Q3'25+14%
$-1.26
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+38.92%
5 Years:+4.68%
3 Years:-6.84%
TTM:+55.90%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-36.92%

Stock Price CAGR

10 Years:+24.52%
5 Years:+30.44%
3 Years:+67.74%
1 Year:+91.12%

Return on Equity

10Y Avg:-74.7%
5Y Avg:-43.9%
3Y Avg:-43.8%
Last Year:-50.6%

Key Metrics

Market Cap$6.8B
Gross Margin37.2%
Net Margin-6.0%
Piotroski F-Score4/9

Frequently Asked Questions

Is MRUS in an uptrend right now?

MRUS has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is MRUS overbought or oversold?

MRUS's RSI (14) is 15. The stock is oversold (RSI < 30), which could indicate a bounce opportunity.

Is MRUS outperforming the market?

MRUS has a Relative Strength (RS) Rating of 86 out of 99. Yes, MRUS is a market leader, outperforming 86% of all stocks over the past 12 months.

Where is MRUS in its 52-week range?

MRUS is trading at $90.00, which is 93% of its 52-week high ($97.14) and 89% above its 52-week low ($33.19).

How volatile is MRUS?

MRUS has a Beta of 0.90 and 52-week volatility of 70%. It's less volatile than the S&P 500 - generally more stable.